Stay updated on Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed, replacing the study record with an error screen. This makes the trial information at this URL unavailable and leaves only general navigation and footer visible.
    Difference
    19%
    Check dated 2026-09-20T01:20:39.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page adds a 2015 NIH grant/contract note to the study details and updates the document revision from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T19:51:46.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a small maintenance update to the page. It does not indicate changes to the study results or core information.
    Difference
    0.1%
    Check dated 2026-08-08T19:16:23.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page's revision tag updates from v3.6.3 to v3.6.4, reflecting a newer internal version in the footer.
    Difference
    0.1%
    Check dated 2026-07-25T12:55:29.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a platform update. This change does not modify the study details, eligibility criteria, outcomes, or other content presented on the page.
    Difference
    0.1%
    Check dated 2026-07-04T04:11:10.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.0 to v3.6.2, signaling a minor platform update to the Study page. This change does not modify study content or visible functionality.
    Difference
    0.1%
    Check dated 2026-06-27T02:03:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.